Cue biopharma to present at three upcoming investor healthcare conferences in november

Boston, nov. 07, 2023 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of t cell engagers to selectively modulate tumor-specific t cells, announced today that it will participate in three investor conferences this november, the stifel healthcare conference, to be held in new york from november 14-15, the jefferies london healthcare conference, to be held in london from november 14-16, and the piper sandler annual healthcare conference, to be held in new york from november 28-30.
CUE Ratings Summary
CUE Quant Ranking